Go to navigation Go to content
Toll-Free: (888) 606-5297
Phone: (859) 578-4444
Schachter, Hendy & Johnson, Attorneys At Law

Canada Finds Testosterone Causes Cardiovascular Problems

Sarah N. Emery
Associate Attorney at Schachter Hendy & Johnson PSC
Posted on Jul 16, 2014

The Canadian government drug regulator, Health Canada, recently announced that testosterone replacement therapy products, like AndroGel and Axiron, "can increase the risk of serious heart and blood vessel problems." This announcement comes at the end of their safety review of testosterone replacement products.

"This review found a growing body of evidence (from published scientific literature and case reports received by Health Canada and foreign reulgators) for serious and possible life-threatening heart and blood vessel problems such as heart attack, stroke, blood clot in the lungs or legs; and incrased or irregular heart rate with the use of testosterone replacement products."

Currently, the FDA is also investigating the safety of testosterone medications with a particular focus on the risks of heart attacks, strokes and other problems. Although the FDA broadened and added warnings concerning the risk of blood clots in the lungs and legs in June 2014, they have yet to issue a final safety finding.

If you or a loved one had a heart attack, stroke, pulmonary embolism or blood clot while taking tesosterone, please call our experienced AndroGel attorneys for a free consultation about your potential AndroGel lawsuit.

Read More About Canada Finds Testosterone Causes Cardiovascular Problems...

Live Chat